InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
ARTV
Result 22 decisions over 12 months
Reset filters
Direction ?
Both22 Bought17 Sold5
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: ARTV Minimum: $100K
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
ARTV Artiva Biotherapeutics, Inc.
8 Sep 2026
Aslan Fred
Chief Executive Officer
Sold on a plan
23,429
$255.75K
1.6%
ARTV Artiva Biotherapeutics, Inc.
3 Sep 2026
Aslan Fred
Chief Executive Officer
Sold at will
61,888
$690.39K
4.0%
ARTV Artiva Biotherapeutics, Inc.
3 Sep 2026
Horan Christopher
Chief Tech Operations Officer
Sold at will
10,366
$115.64K
3.5%
ARTV Artiva Biotherapeutics, Inc.
31 Jul 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
24,944
$247.69K
0.1%
ARTV Artiva Biotherapeutics, Inc.
29 Jul 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
20,824
$208.03K
0.1%
ARTV Artiva Biotherapeutics, Inc.
24 Jul 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
41,319
$412.78K
0.2%
ARTV Artiva Biotherapeutics, Inc.
23 Jul 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
59,880
$596.40K
0.3%
ARTV Artiva Biotherapeutics, Inc.
22 Jul 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
84,124
$835.35K
0.5%
ARTV Artiva Biotherapeutics, Inc.
21 Jul 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
120,582
$1.15M
0.7%
ARTV Artiva Biotherapeutics, Inc.
16 Jul 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
152,472
$1.36M
0.9%
ARTV Artiva Biotherapeutics, Inc.
10 Jul 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
15,102
$135.46K
0.1%
ARTV Artiva Biotherapeutics, Inc.
25 Jun 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
31,000
$275.28K
0.2%
ARTV Artiva Biotherapeutics, Inc.
16 Jun 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
124,893
$1.11M
0.8%
ARTV Artiva Biotherapeutics, Inc.
15 Jun 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
15,414
$138.57K
0.1%
ARTV Artiva Biotherapeutics, Inc.
12 Jun 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
391,019
$3.35M
2.4%
ARTV Artiva Biotherapeutics, Inc.
11 Jun 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
548,580
$4.34M
3.5%
ARTV Artiva Biotherapeutics, Inc.
9 Jun 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
479,039
$3.31M
3.2%
ARTV Artiva Biotherapeutics, Inc.
19 May 2026
Aslan Fred
Chief Executive Officer
Sold at will
27,116
$244.25K
1.7%
ARTV Artiva Biotherapeutics, Inc.
11 May 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Bought
6,510,416
$75.00M
74.9%
ARTV Artiva Biotherapeutics, Inc.
11 May 2026
GC Corp.
10% owner
Bought
1,085,069
$12.50M
32.8%
ARTV Artiva Biotherapeutics, Inc.
11 May 2026
GC Corp.
10% owner indirect
Bought
347,222
$4.00M
27.5%
ARTV Artiva Biotherapeutics, Inc.
17 Oct 2025
Aslan Fred
President and CEO
Sold on a plan
25,500
$153.00K
6.7%
Showing 1–22 of 22.